Patents, Bio Rad Laboratories Inc, 10x Genomics, Microfluidics, Single Cell Sequencing.
already written that way. I also appreciate simply swapping a component with something equivalent but unavailable at time of filing doesn’t circumvent the patent. But how to determine the equivalence? Prior arts In principle, if an inventor attempts to claim something very broad, it might be